GENETIC SUSCEPTIBILITY TO ATHEROSCLEROSIS

被引:19
作者
CHAMBERLAIN, JC
GALTON, DJ
机构
[1] Department of Human Genetics and Metabolism, Medical Professorial Unit, St. Bartholomew's Hospital, London
基金
英国医学研究理事会;
关键词
D O I
10.1093/oxfordjournals.bmb.a072446
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Genetic factors are implicated in atherogenesis by family and twin studies of coronary artery disease, interacting with the environment to produce the phenotypic disease. Restriction fragment length polymorphisms provide useful linkage markers with which to study the genetics of this disease, the effectiveness of marker loci being characterized in terms of their polymorphism information content.Other forms of nucleotide variation, including variable number of tandem repeats can also provide linkage markers for aetiological loci and can be detected by the use of polymerase chain amplification followed by sequencing, denaturing gel electrophoresis, base pair specific chemical cleavage or the use of oligonucleotide probes. Linkage markers may be used either in population association or familial studies. Candidate genes may be studied or complete genomic mapping attempted.A review of potential candidate genes for atherosclerosis is presented. © 1990 The British Council.
引用
收藏
页码:917 / 940
页数:24
相关论文
共 62 条
[1]  
ARMSTRONG VW, 1985, J LIPID RES, V26, P1314
[2]  
ASSMAN G, 1989, ATHEROSCLEROSIS, V75, P34
[3]  
ASSMANN G, 1989, ATHEROSCLEROSIS, V75, P341
[4]  
BAGGIO G, 1986, P NATO ADV RES WORKS, P203
[5]  
BERG K, 1963, ACTA PATHOL MIC SC, V59, P369
[6]   TWIN STUDIES OF CORONARY HEART-DISEASE AND ITS RISK-FACTORS [J].
BERG, K .
ACTA GENETICAE MEDICAE ET GEMELLOLOGIAE, 1984, 33 (03) :349-361
[7]  
BERG K, 1983, PROGR MED GENETICS, V5, P36
[8]  
BOTSTEIN D, 1980, AM J HUM GENET, V32, P314
[9]   DNA POLYMORPHISMS AT THE LIPOPROTEIN-LIPASE GENE - ASSOCIATIONS IN NORMAL AND HYPERTRIGLYCERIDEMIC SUBJECTS [J].
CHAMBERLAIN, JC ;
THORN, JA ;
OKA, K ;
GALTON, DJ ;
STOCKS, J .
ATHEROSCLEROSIS, 1989, 79 (01) :85-91
[10]  
CHAMBERLAIN JC, 1989, ATHEROSCLEROSIS, V75, P209